Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Siglec-2/CD22 Protein, Human, Recombinant (aa 176-687, His)

(Synonyms: SIGLEC-2, SIGLEC2, CD22 molecule) Copy Product Info

Synonyms: SIGLEC-2, SIGLEC2, CD22 molecule

Catalog No. TMPY-03566 Copy Product Info
Siglec-2/CD22 Protein, Human, Recombinant (aa 176-687, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 58.5 kDa and the accession number is Q32M46.

Product Information

Bioactivity
Bioactivity
1.Immobilized Anti-CD22 Antibody, human IgG1 at 2 μg/mL (100 μL/well) can bind Recombinant Human Siglec-2/CD22 Protein (aa 176-687, His Tag) (Cat#TMPY-03566), the EC50 is 8-25 ng/mL.
2.Loaded Anti-Human CD22 Antibody, Human IgG1 on AHC Biosensor, can bind Recombinant Human Siglec-2/CD22 Protein (aa 176-687), His Tag (Cat#TMPY-03566) with an affinity constant of 5.92 nM as determined in BLI assay (Sartorius Octet RED384) (Routinely tested).
3.Monoclonal anti-Human Siglec-2 Antibody, human IgG1 captured on Protein A chip can bind Recombinant Human Siglec-2/CD22 Protein (aa 176-687), His Tag (Cat#TMPY-03566) with an affinity constant of 2.147 nM as determined in an SPR assay (Biacore T200) (Routinely tested).
Description
Siglec-2/CD22 Protein, Human, Recombinant (aa 176-687, His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 58.5 kDa and the accession number is Q32M46.
Species
Human
Expression System
HEK293 Cells
TagC-His
Accession NumberQ32M46
ConstructionA DNA sequence encoding the human CD22 (Q32M46) (Trp176-Arg687) was fused with a polyhistidine tag at the C-terminus. Predicted N terminal: Trp 176
Protein Purity
> 90 % as determined by SDS-PAGE
Endotoxin< 1.0 EU/μg of the protein as determined by the LAL method.
FormulationLyophilized from a solution filtered through a 0.22 μm filter, containing PBS, pH 7.4. Typically, a mixture containing 5% to 8% trehalose, mannitol, and 0.01% Tween 80 is incorporated as a protective agent before lyophilization.
ReconstitutionA Certificate of Analysis (CoA) containing reconstitution instructions is included with the products. Please refer to the CoA for detailed information.
SynonymsSIGLEC-2, SIGLEC2, CD22 molecule
Research Background
CD22 is a member of the immunoglobulin superfamily, SIGLEC family of lectins. It is first expressed in the cytoplasm of pro-B and pre-B cells, and on the surface as B cells mature to become IgD+. CD22 serves as an adhesion receptor for sialic acid-bearing ligands expressed on erythrocytes and all leukocyte classes. In addition to its potential role as a mediator of intercellular interactions, signal transduction through CD22 can activate B cells and modulate antigen receptor signaling in vitro. The phenotype of CD22-deficient mice suggests that CD22 is primarily involved in the generation of mature B cells within the bone marrow, blood, and marginal zones of lymphoid tissues. CD22 recruits the tyrosine phosphatase Src homology 2 domain-containing phosphatase 1 (SHP-1) to immunoreceptor tyrosine-based inhibitory motifs (ITIMs) and inhibits B-cell receptor (BCR)-induced Ca2+ signaling on normal B cells. CD22 interacts specifically with ligands carrying alpha2-6-linked sialic acids. As an inhibitory coreceptor of the B-cell receptor (BCR), CD22 plays a critical role in establishing signalling thresholds for B-cell activation. Like other coreceptors, the ability of CD22 to modulate B-cell signalling is critically dependent upon its proximity to the BCR, and this in turn is governed by the binding of its extracellular domain to alpha2,6-linked sialic acid ligands. However, genetic studies in mice reveal that some CD22 functions are regulated by ligand binding, whereas other functions are ligand-independent and may only require expression of an intact CD22 cytoplasmic domain at the B-cell surface. CD19 regulates CD22 phosphorylation by augmenting Lyn kinase activity, while CD22 inhibits CD19 phosphorylation via SHP-1.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy
Chemical Properties
Molecular Weight58.5 kDa (predicted); 90-100 kDa (reducing condition, due to glycosylation)
Storage & Solubility Information
ShippingIn general, lyophilized powders are shipped with blue ice, while solutions are shipped with dry ice.
StorageIt is recommended to store recombinant proteins at -20°C to -80°C for future use. Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.

Calculator

  • Reconstitution Calculator
  • Recombinant Protein Dilution Calculator
  • Specific Activity Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Keywords

Related Tags: Siglec-2/CD22 Protein, Human, Recombinant (aa 176-687, His) chemical structure | Siglec-2/CD22 Protein, Human, Recombinant (aa 176-687, His) molecular weight